Strategic Acquisitions (STQN) Net Income towards Common Stockholders (2018 - 2026)
Strategic Acquisitions' (STQN) quarterly Net Income towards Common Stockholders came in at -$77434.0 in Q1 2026, down 291.38% on a YoY basis from $40461.4 in Q1 2025, and down 26.33% quarter-over-quarter from -$61294.0 in Q4 2025.
Powered by 
Analysis
Strategic Acquisitions (STQN) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Strategic Acquisitions (STQN) has reported Net Income towards Common Stockholders for 9 consecutive years, with -$77434.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 291.38% year-over-year to -$77434.0; the trailing twelve-month figure through Mar 2026 stood at -$138095.0 (up 40.7% YoY), and the FY2025 full-year result was -$80446.0, up 67.49% from the prior year.
- Net Income towards Common Stockholders declined to -$77434.0 in Q1 2026 per STQN's latest filing, from -$61294.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $139466.0 in Q3 2022 and bottomed at -$171666.0 in Q4 2024.
- Historically, Net Income towards Common Stockholders has averaged -$30895.0 across 5 years, with a median of -$28947.5 in 2022.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders soared 3114.18% in 2022, then tumbled 394.1% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at $139466.0 in 2022, then tumbled by 124.91% to -$34743.0 in 2023, then sank by 394.1% to -$171666.0 in 2024, then soared by 64.29% to -$61294.0 in 2025, then decreased by 26.33% to -$77434.0 in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$77434.0, -$61294.0, and $2645.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn | 1.76 Bn |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - | 81.49 Mn |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn | 237.56 Mn |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn | 87.48 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn | 64.00 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn | 47.41 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - | 41.30 Mn |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - | -131.57 Mn |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn | 21.58 Mn |
| 10 | Strategic Acquisitions | 18.20 Mn | 17.95 Mn | - | -77,434.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -77,434.00 |
| Dec 31, 2025 | -61,294.00 |
| Sep 30, 2025 | 2,645.00 |
| Jun 30, 2025 | -2,012.00 |
| Mar 31, 2025 | -19,785.00 |
| Dec 31, 2024 | -171,666.00 |
| Sep 30, 2024 | -23,659.00 |
| Jun 30, 2024 | -17,782.00 |
| Mar 31, 2024 | -34,325.00 |
| Dec 31, 2023 | -34,743.00 |
| Sep 30, 2023 | -136,052.00 |
| Jun 30, 2023 | 29,774.00 |
| Mar 31, 2023 | -45,822.00 |
| Sep 30, 2022 | 139,466.00 |
| Jun 30, 2022 | -7,395.00 |
| Mar 31, 2022 | -34,236.00 |
| Dec 31, 2021 | -3,740.00 |
| Sep 30, 2021 | -4,627.00 |
| Jun 30, 2021 | -3,600.00 |
| Mar 31, 2021 | -10,126.00 |